Emergent Biosolutions INC.
biopharmaceutical company
Based in DC
AI Overview
With $650K in lobbying spend across 13 quarterly filings, Emergent Biosolutions INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $50K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Emergent Biosolutions INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Defense, Health Issues, Homeland Security
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government
FY 2019 Appropriations - provisions related to development,
H.R.2810 - National Defense Authorization Act for Fiscal Year 2018, provisions related to biological and chemical defense
Issues related to homeland security, emergency preparedness and response, the reauthorization of the Pandemic and All-Hazards Preparedness Act, and the strategic national vaccine stockpile.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.